Flk-1/VEGFR2 (phospho Tyr1214) Polyclonal Antibody

Alias:KDR;FLK1;VEGFR2;Vascular endothelial growth factor receptor 2;VEGFR-2;Fetal liver kinase 1;FLK-1;Kinase insert domain receptor;KDR;Protein-tyrosine kinase receptor flk-1;CD antigen CD309

CatalogNo:HJRLP0111

Specifications

50μL;100μL

Delivery date

Spot

Target

Flk-1/VEGFR2

Reactivity

Human,Mouse,Rat

Application - After Update

WB,IHC,IF,ELISA

MW(Observed)

152kD

Host Species

Rabbit

Isotype

IgG

Modify

Phospho

Recommended dilution ratio

WB 1:500-1:2000;IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:10000;Not yet tested in other applications.

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from human VEGFR2 around the phosphorylation site of Tyr1214. AA range:1180-1229

Specificity

Phospho-Flk-1 (Y1214) Polyclonal Antibody detects endogenous levels of Flk-1 protein only when phosphorylated at Y1214.

Gene name

KDR

Protein name

Vascular endothelial growth factor receptor 2

Organism-1

Human